Journal Information
Most often read
5039
Evolving portal hypertension through Baveno VII recommendationsManuel Mendizabal, Guilherme Grossi Lopes Cançado, Agustín Albillos
Ann Hepatol. 2024;29:101180
5039
Full text access
4146
A multisociety Delphi consensus statement on new fatty liver disease nomenclatureMary E. Rinella, Jeffrey V. Lazarus, Vlad Ratziu, Sven M. Francque, Arun J. Sanyal, Fasiha Kanwal, Diana Romero, Manal F. Abdelmalek, ... NAFLD Nomenclature consensus group
Ann Hepatol. 2024;29:101133
4146
Full text access
3601
Administration of silymarin in NAFLD/NASH: A systematic review and meta-analysisShudi Li, Fei Duan, Suling Li, Baoping Lu
Ann Hepatol. 2024;29:101174
3601
Full text access
![](https://static.elsevier.es/multimedia/16652681/0000002900000002/v4_202406130720/S1665268123002776/v4_202406130720/en/main.assets/ga1.jpeg)
3193
From NAFLD to MASLD: When metabolic comorbidity mattersShan Hong, Lei Sun, Yiwei Hao, Ping Li, Yuling Zhou, Xiuxia Liang, Julong Hu, Hongshan Wei
Ann Hepatol. 2024;29:101281
3193
Full text access
![](https://static.elsevier.es/multimedia/16652681/0000002900000002/v4_202406130720/S1665268123003848/v4_202406130720/en/main.assets/ga1.jpeg)
3184
Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cellsShuguang Pan, Ying Hu, Lang Gan, Jiejuan Lai, Ping Zheng, YuJun Zhang, Ling Shuai, Yan Jiang, ... Yu He
Ann Hepatol. 2024;29:101279
3184
Full text access
2953
Alcohol-associated liver disease: Epidemiology and managementHelena Hernández-Évole, Natalia Jiménez-Esquivel, Elisa Pose, Ramón Bataller
Ann Hepatol. 2024;29:101162
2953
Full text access
2040
The burden of liver disease in Latin AmericaLuis Antonio Díaz, Marcela Villota-Rivas, Francisco Barrera, Jeffrey V. Lazarus, Marco Arrese
Ann Hepatol. 2024;29:101175
2040
Full text access
2011
Why a pinch of zinc in liver disease mattersKurt Grüngreiff, Dirk Reinhold, Wolfgang Maret
Ann Hepatol. 2024;29:101152
2011
Full text access
1547
Schistosomiasis: A neglected cause of liver disease in the PhilippinesAlexander M. Sy
Ann Hepatol. 2024;29:101166
1547
Full text access
1441
From evidence to clinical practice: Bridging the gap of new liver cancer therapies in Latin America.Federico Piñero, Ezequiel Mauro, Paola Casciato, Alejandro Forner
Ann Hepatol. 2024;29:101185
1441
Full text access
1251
Optimal ALT threshold for the automated diagnosis of MASLD: A population-based study using iLFTJeremy Lee, Christopher J. Byrne, Paul N. Brennan, Iain MacPherson, Eleanor Dow, John F. Dillon
Ann Hepatol. 2024;29:101280
1251
Full text access
1187
Liquid biopsy: New opportunities for precision medicine in hepatocellular carcinoma careInah Marie C. Aquino, Devis Pascut
Ann Hepatol. 2024;29:101176
1187
Full text access
1107
Prevalence of occult hepatitis B virus infection and characterisation of hepatitis B surface antigen mutants among adults in western CroatiaMarina Bubonja-Šonje, Dolores Peruč, Maja Abram, Bojana Mohar-Vitezić
Ann Hepatol. 2024;29:101156
1107
Full text access
1074
Pathophysiology of ascites: The importance of the intestine. A surgical contribution to the understanding of a medical problemGabriel E. Gondolesi, Carolina Rumbo, Leonardo Montes, Lucia Novellis, Diego Ramisch, Ariel Riquelme Henríquez, Mariana Ortega, Federico Viano, ... Héctor Solar
Ann Hepatol. 2024;29:101498
1074
Full text access
1057
A data-driven approach to decode metabolic dysfunction-associated steatotic liver diseaseMaria Jimenez Ramos, Timothy J. Kendall, Ignat Drozdov, Jonathan A. Fallowfield
Ann Hepatol. 2024;29:101278
1057
Full text access
1046
From NAFLD to MASLD: Promise and pitfalls of a new definitionKenneth Cusi, Zobair Younossi, Michael Roden
Ann Hepatol. 2024;29:101179
1046
Full text access
963
Overall and subgroup prevalence of non-alcoholic fatty liver disease and prevalence of advanced fibrosis in the United States: An updated national estimate in National Health and Nutrition Examination Survey (NHANES) 2011-2018Tongtong Wang, Yuzhi Xi, Annaswamy Raji, Michael Crutchlow, Gail Fernandes, Samuel S Engel, Xiao Zhang
Ann Hepatol. 2024;29:101154
963
Full text access
960
Global prevalence of occult HBV infection in children and adolescents: A systematic review and meta-analysisJiaying Wu, Jiayao He, Hongmei Xu
Ann Hepatol. 2024;29:101158
960
Full text access
937
NAFLD is associated with less severe liver fibrosis in chronic hepatitis B: A multi-center, retrospective studyRenling Yao, Sufang Lu, Ruifei Xue, Jian Wang, Yuanwang Qiu, Yuxin Chen, Jiacheng Liu, Li Zhu, ... Chao Wu
Ann Hepatol. 2024;29:101155
937
Full text access
914
Stemness markers in hepatocellular carcinoma of Eastern vs. Western population: Etiology matters?Caecilia HC Sukowati, Korri El-Khobar, Chyntia Olivia Maurine Jasirwan, Juferdy Kurniawan, Rino Alvani Gani
Ann Hepatol. 2024;29:101153
914
Full text access